HIT-RE 100, B

Hilti (Schweiz) AG

Revision date : 2022-11-18

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS05 GHS07
Health risk rating 4
Safety risk rating 1
Environmental risk rating 3

Note: Ingredients listed on restricted chemical lists

EC/CAS

216-032-5/1477-55-0

Name of the chemical

1,3-benzenedimethanamine

Concentration

25-40

EC/CAS

203-585-2/108-46-3

Name of the chemical

Resorcinol

Concentration

0,1-1

General Information

Version

2.1

Revision date

2022-11-18

Product name

HIT-RE 100, B

1.2.1 Relevant identified uses

Industrial/Professional use spec

Emergency telephone

+41 44 251 51 51

Icons in SDS

GHS05 GHS07 M004 M009 M010 T031

Company Information

company name

Hilti (Schweiz) AG

e-mail address of the competent person responsible for the Safety Data Sheet

info@hilti.ch, anchor.hse@hilti.com

GHS Information

Signal word

Contains

Hazard Codes

Hazard statements (CLP)

H302, H314, H317, H318, H412

Hazard statements

Code

Statements

H302

Harmful if swallowed

Section 2

SECTION 2: Hazards identification

Adverse physicochemical, human health and environmental effects

No additional information available 2.2. Label elements Labelling

Hazard pictograms

GHS05 GHS07

Signal word

Contains Danger Formaldehyde, telomer with 1,3-benzenedimethanamine, 1,3-benzenediol and ethenylbenzene, resorcinol, m-Xylylenediamine

Hazard statements

H314 - Causes severe skin burns and eye damage. H317 - May cause an allergic skin reaction. H412 - Harmful to aquatic life with long lasting effects.

Precautionary statements

P280 - Wear eye protection, protective clothing, protective gloves. P262 - Do not get in eyes, on skin, or on clothing. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P302+P352 - IF ON SKIN: Wash with plenty of water. P337+P313 - If eye irritation persists: Get medical advice/attention. P333+P313 - If skin irritation or rash occurs: Get medical advice/attention.

2.3 Other hazards

This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component m-Xylylenediamine (1477-55-0) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Formaldehyde, telomer with 1,3- benzenedimethanamine, 1,3-benzenediol and ethenylbenzene (710292-85-6) resorcinol (108-46-3) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component m-Xylylenediamine(1477-55-0) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Formaldehyde, telomer with 1,3- benzenedimethanamine, 1,3-benzenediol and ethenylbenzene(710292-85-6) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 resorcinol(108-46-3) ED: not yet assessed

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.